Global Methotrexate Sales Market Report 2021

Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.
Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis.
The technical barriers of methotrexate are not high, and the methotrexate enterprise concentrate in China, USA, Australia, and the relative large companies include Teva Pharmaceutical Industries, Qualitestrx (DAVA Pharmaceuticals), Pfizer (Hospira), Roxane Laboratories, Sine, Maoxiang, LingNan Pharmaceutical and others.

Market Analysis and Insights: Global Methotrexate Market
The global Methotrexate market was valued at US$ 517.2 in 2020 and will reach US$ 606.9 million by the end of 2027, growing at a CAGR of 2.7% during 2022-2027.

Global Methotrexate Scope and Market Size
The global Methotrexate market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Methotrexate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Methotrexate for Injection
Methotrexate Tablets

Segment by Application
Used for Cancers
Used for Rheumatoid Arthritis
Used for Other Diseases

The Methotrexate market is analysed and market size information is provided by regions (countries). Segment by Application, the Methotrexate market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Teva Pharmaceutical Industries
Qualitestrx(DAVA Pharmaceuticals)
Pfizer (Hospira)
Roxane Laboratories
Sine
Maoxiang
LingNan Pharmaceutical
Powerdone
Huiyu